Generalizability of sodium-glucose co-transporter-2 inhibitors cardiovascular outcome trials to the type 2 diabetes population: a systematic review and meta-analysis

Faculty Opinions recommendation of SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734434782.793555944 ◽

2019 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Renal Outcomes

Cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Asians with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials

Diabetes & Metabolic Syndrome Clinical Research & Reviews ◽

10.1016/j.dsx.2020.04.051 ◽

2020 ◽

Vol 14 (4) ◽

pp. 715-722

Author(s):

Awadhesh Kumar Singh ◽

Ritu Singh

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Cardiovascular Outcome ◽

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet ◽

10.1016/s0140-6736(18)32590-x ◽

2019 ◽

Vol 393 (10166) ◽

pp. 31-39 ◽

Cited By ~ 749

Author(s):

Thomas A Zelniker ◽

Stephen D Wiviott ◽

Itamar Raz ◽

Kyungah Im ◽

Erica L Goodrich ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Renal Outcomes

Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials

Endocrine ◽

10.1007/s12020-019-01931-y ◽

2019 ◽

Vol 65 (1) ◽

pp. 15-24 ◽

Cited By ~ 6

Author(s):

Dario Giugliano ◽

Maria Ida Maiorino ◽

Miriam Longo ◽

Giuseppe Bellastella ◽

Paolo Chiodini ◽

...

Keyword(s):

Heart Failure ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(19)30249-9 ◽

2019 ◽

Vol 7 (10) ◽

pp. 776-785 ◽

Cited By ~ 208

Author(s):

Søren L Kristensen ◽

Rasmus Rørth ◽

Pardeep S Jhund ◽

Kieran F Docherty ◽

Naveed Sattar ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Cardiovascular Mortality ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Receptor Agonists

Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(20)30038-3 ◽

2020 ◽

Vol 8 (5) ◽

pp. 418-435 ◽

Cited By ~ 19

Author(s):

Olivia R Ghosh-Swaby ◽

Shaun G Goodman ◽

Lawrence A Leiter ◽

Alice Cheng ◽

Kim A Connelly ◽

...

Keyword(s):

Heart Failure ◽

Systematic Review ◽

Type 2 Diabetes ◽

At Risk ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Glucose Lowering ◽

Effect of background insulin therapy on cardiovascular outcomes with SGLT-2 inhibitors in type 2 diabetes: A Meta-analysis of Cardiovascular Outcome Trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.108648 ◽

2021 ◽

pp. 108648

Author(s):

Awadhesh Kumar Singh ◽

Ritu Singh

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Cardiovascular Outcome ◽

SYSTEMATIC REVIEW OF PREVALENT AND INCIDENT HEART FAILURE IN CARDIOVASCULAR OUTCOME TRIALS OF PATIENTS WITH TYPE 2 DIABETES

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(18)31338-x ◽

2018 ◽

Vol 71 (11) ◽

pp. A797

Author(s):

Stephen Greene ◽

Muthiah Vaduganathan ◽

Muhammad Khan ◽

George Bakris ◽

Matthew Weir ◽

...

Keyword(s):

Heart Failure ◽

Systematic Review ◽

Type 2 Diabetes ◽

Cardiovascular Outcome ◽

Incident Heart Failure

Comparison of New Glucose-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes: A Network Meta-Analysis of Cardiovascular Outcome Trials

SSRN Electronic Journal ◽

10.2139/ssrn.3436269 ◽

2019 ◽

Author(s):

Caroline K. Kramer ◽

Chang Ye ◽

Ravi Retnakaran

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Secondary Prevention ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Glucose Lowering ◽

Prevention Of Cardiovascular Disease

Update on Cardiovascular Safety of Incretin-Based Therapy in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.04.003 ◽

2019 ◽

Vol 43 (7) ◽

pp. 538-545.e2 ◽

Cited By ~ 4

Author(s):

Osamah M. Alfayez ◽

Abdulaali R. Almutairi ◽

Ali Aldosari ◽

Majed S. Al Yami

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Cardiovascular Safety ◽